Skip to main content
×
×
Home
  • Print publication year: 2014
  • Online publication date: May 2014

Chapter 18 - Neuronal death and rescue: neurotrophic factors and anti-apoptotic mechanisms

from Section 4 - Neural repair: basic cellular and molecular processes
Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Textbook of Neural Repair and Rehabilitation
  • Online ISBN: 9780511995583
  • Book DOI: https://doi.org/10.1017/CBO9780511995583
Please enter your name
Please enter a valid email address
Who would you like to send this to *
×

References

1. VilaM, PrzedborskiS. Targeting programmed cell death in neuro-degenerative diseases. Nat Rev Neurosci 2003; 4: 365–75.
2. OppenheimRW, von BartheldCS. Programmed cell death and neurotrophic factors. In SquireL, BergD, BloomF, et al., eds. Fundamental Neuroscience 3rd edn. New York, NY: Elsevier, 2008; 437–68.
3. YuanJ, YanknerBA. Apoptosis in the nervous system. Nature 2000; 407: 802–9.
4. ElliottJL, SniderWD. Axotomy-induced motor neuron death. In KoliatosV,RatanR, eds. Cell Death and Diseases of the Nervous System. Totowa, NJ: Humana Press, 1999; 181–95.
5. HiltDC, MillerJA, MaltaE. Early experiences with trophic factors as drugs for neurological disease: brain-derived neurotrophic factor and ciliary neurotrophic factor for ALS. In KoliatosV, RatanR, eds. Cell Death and Diseases of the Nervous System. Totowa, NJ: Humana Press, 1999; 593–607.
6. GouldTW, OppenheimRW. Motor neuron trophic factors: therapeutic use in ALS?Brain Res Rev 2011; 67: 1–39.
7. HamburgerV. Regression versus peripheral control of differentiation in motor hypoplasia. Am J Anat 1958; 102: 365–409.
8. GouldTW, EnomotoH. Neurotrophic modulation of motor neuron development. Neuroscientist 2009; 15: 105–16.
9. SavillJ, GregoryC, HaslettC. Cell biology Eat me or die. Science 2003; 302: 1516–17.
10. WyllieAH, KerrJF, CurrieAR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251–306.
11. ClarkePG, ClarkeS. Nineteenth century research on naturally occurring cell death and related phenomena. Anat Embryol (Berlin) 1996; 193: 81–99.
12. DattaSR, KatsovA, HuL, et al. 14–3–3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell 2000; 6: 41–51.
13. DegterevA, YuanJ. Expansion and evolution of cell death programmes. Nat Rev Mol Cell Biol 2008; 9: 378–90.
14. KourtisN, TavernarakisN. Autophagy and cell death in model organisms. Cell Death Differ 2009; 16: 21–30.
15. ChoDH, NakamuraT, LiptonSA. Mitochondrial dynamics in cell death and neurodegeneration. Cell Mol Life Sci 2010; 67: 3435–47.
16. LamkanfiM, FestjensN, DeclercqW, et al. Caspases in cell survival, proliferation and differentiation. Cell Death Differ 2007; 14: 44–55.
17. LiZ, JoJ, JiaJM, et al. Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. Cell 2010; 141: 859–71.
18. MallatM, Marín-TevaJL, ChéretC. Phagocytosis in the developing CNS: more than clearing the corpses. Curr Opin Neurobiol 2005; 15: 101–7.
19. WiegandUK, CorbachS, PrescottAR, et al. The trigger to cell death determines the efficiency with which dying cells are cleared by neighbours. Cell Death Differ 2001; 8: 734–46.
20. ElliottMR, ChekeniFB, TrampontPC, et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 2009; 461: 282–6.
21. LauberK, BohnE, KröberSM, et al. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 2003; 113: 717–30.
22. KinchenJM, RavichandranKS. Journey to the grave: signaling events regulating removal of apoptotic cells. J Cell Sci 2007; 120: 2143–9.
23. JellingerKA. Basic mechanisms of neurodegeneration: a critical update. J Cell Mol Med 2010; 14: 457–87.
24. RangasamySB, SoderstromK, BakayRA, et al. Neurotrophic factor therapy for Parkinson’s disease. Prog Brain Res 2010; 184: 237–64.
25. CourchesneE, PierceK, SchumannCM, et al. Mapping early brain development in autism. Neuron 2007; 56: 399–413.
26. YounkinSG. The role of Ab42 in Alzheimer’s disease. J Physiol (Paris) 1998; 92: 289–92.
27. ZhengH, KooEH. The amyloid precursor protein: beyond amyloid. Mol Neurodegener 2006; 1: 5.
28. SmithMA, DrewKL, NunomuraA, et al. Amyloid-beta, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs?Neurochem Int 2002; 40: 527–31.
29. CooksonMR. A-Synuclein and neuronal cell death. Mol Neurodegener 2009; 4: 9.
30. CelsiF, PizzoP, BriniM, et al. Mitochondria, calcium and cell death: a deadly triad in neurodegeneration. Biochim Biophys Acta 2009; 1787: 335–44.
31. MariesE, DassB, CollierTJ, et al. The role of alpha-synuclein in Parkinson’s disease: insights from animal models. Nat Rev Neurosci 2003; 4: 727–3.
32. The Huntington’s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 1993; 72: 971–83.
33. LiSH, LiXJ. Huntingtin and its role in neuronal degeneration. Neuroscientist 2004; 10: 467–75.
34. BrownRH Jr. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 1995; 80: 687–92.
35. TraubR, MitsumotoH, RowlandLP. Research advances in amyotrophic lateral sclerosis, 2009 to 2010. Curr Neurol Neurosci Rep 2011; 11: 67–77.
36. DengHX, ChenW, HongST, et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 2011; 477: 211–15.
37. Dejesus-HernandezM, MackenzieIR, BoeveBF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011; 72: 245–56.
38. RentonAE, MajounieE, WaiteA, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011; 72: 257–68.
39. KaoAW, EisenhutRJ, MartensLH, et al. A neurodegenerative disease mutation that accelerates the clearance of apoptotic cells. Proc Natl Acad Sci U S A 2011; 108: 4441–6.
40. MiglioreL, CoppedèF. Environmental-induced oxidative stress in neurodegenerative disorders and aging. Mutat Res 2009; 674: 73–84.
41. WangY, QinZH. Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis 2010; 15: 1382–402.
42. KnottAB, PerkinsG, SchwarzenbacherR, et al. Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci 2008; 9: 505–18.
43. MartinLJ. Mitochondrial pathobiology in Parkinson’s disease and amyotrophic lateral sclerosis. J Alzheimers Dis 2010; 20: S335–56.
44. LiH, ChenY, JonesAF, et al. Bcl-xL induces Drp1-dependent synapse formation in cultured hippocampal neurons. Proc Natl Acad Sci U S A 2008; 105: 2169–74.
45. BermanSB, PinedaFJ, HardwickJM. Mitochondrial fission and fusion dynamics: the long and short of it. Cell Death Differ 2008; 15: 1147–52.
46. WakabayashiT. Megamitochondria formation–physiology and pathology. J Cell Mol Med 2002; 6: 497–538.
47. BermanSB, ChenYB, QiB, et al. Bcl-x L increases mitochondrial fission, fusion, and biomass in neurons. J Cell Biol 2009; 184: 707–19.
48. HickmanJA, HardwickJM, KaczmarekLK, JonasEA, et al. cl-xL inhibitor ABT-737 reveals a dual role for Bcl-xL in synaptic transmission. J Neurophysiol 2008; 99: 1515–22.
49. KarbowskiM, LeeYJ, GaumeB, et al. Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J Cell Biol 2002; 159: 931–8.
50. KarbowskiM, NorrisKL, ClelandMM, et al. Role of Bax and Bak in mitochondrial morphogenesis. Nature 2006; 443: 658–62.
51. WangH, LimPJ, KarbowskiM, et al. Effects of overexpression of huntingtin proteins on mitochondrial integrity. Hum Mol Genet 2009; 18: 737–52.
52. ChooYS, JohnsonGV, MacDonaldM, et al. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum Mol Genet 2004; 13: 1407–20.
53. MagranéJ, ManfrediG. Mitochondrial function, morphology, and axonal transport in amyotrophic lateral sclerosis. Antioxid Redox Signal 2009; 11: 1615–26.
54. ManfrediG, XuZ. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Mitochondrion 2005; 5: 77–87.
55. ShiP, WeiY, ZhangJ, et al. Mitochondrial dysfunction is a converging point of multiple pathological pathways in amyotrophic lateral sclerosis. J Alzheimers Dis 2010; 20: S311–24.
56. MurakamiT, NagaiM, MiyazakiK, et al. Early decrease of mitochondrial DNA repair enzymes in spinal motor neurons of presymptomatic transgenic mice carrying a mutant SOD1 gene. Brain Res 2007; 1150: 182–9.
57. ReddyPH, ReddyTP, ManczakM, et al. Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases. Brain Res Rev 2011; 67: 103–18.
58. IsraelsonA, ArbelN, Da CruzS, et al. Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron 2010; 67: 575–87.
59. PedriniS, SauD, GuareschiS, et al. ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2. Hum Mol Genet 2010; 19: 2974–86.
60. VabulasRM, HartlFU. Aberrant protein interactions in amyloid disease. Cell Cycle 2011; 10: 1512–13.
61. KaushikS, CuervoAM. Autophagy as a cell-repair mechanism: activation of chaperone-mediated autophagy during oxidative stress. Mol Aspects Med 2006; 27: 444–54.
62. LüdersJ, DemandJ, HöhfeldJ. The ubiquitin-related BAG-1 provides a link between the molecular chaperones Hsc70/Hsp70 and the proteasome. J Biol Chem 2000; 275: 4613–17.
63. RitossaF. A new puffing pattern induced by termperature shock and DNP in Drosophila. Experientia 1962; 15: 571–3.
64. RitossaF. Discovery of the heat shock response. Cell Stress Chaperones 1996; 1: 97–8.
65. KregelKC. Heat shock proteins: modifying factors in physiological stress responses and acquired thermotolerance. J Appl Physiol 2002; 92: 2177–86.
66. MorimotoRI, KlineMP, BimstonDN, et al. The heat-shock response: regulation and function of heat-shock proteins and molecular chaperones. Essays Biochem 1997; 32: 17–29.
67. SchlesingerMJ. Heat shock proteins. J Biol Chem 1990; 265: 12111–14.
68. WelchWJ. Mammalian stress response: cell physiology, structure/function of stress proteins, and implications for medicine and disease. Physiol Rev 1992; 72: 1063–81.
69. PirkkalaL, NykanenP, SistonenL. Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. Faseb J 2001; 15: 1118–31.
70. OstlingP, BjörkJK, Roos-MattjusP, et al. Heat shock factor 2 (HSF2) contributes to inducible expression of hsp genes through interplay with HSF1. J Biol Chem 2007; 282: 7077–86.
71. SantoroMG. Heat shock factors and the control of the stress response. Biochem Pharmacol 2000; 59: 55–63.
72. MorimotoRI. Cells in stress: transcriptional activation of heat shock genes. Science 1993; 259: 1409–10.
73. AhnSG, ThieleDJ. Redox regulation of mammalian heat shock factor 1 is essential for Hsp gene activation and protection from stress. Genes Dev 2003; 17: 516–28.
74. ZhongM, OroszA, WuC. Direct sensing of heat and oxidation by Drosophila heat shock transcription factor. Mol Cell 1998; 2: 101–8.
75. ChangY, OstlingP, AkerfeltM, et al. Role of heat-shock factor 2 in cerebral cortex formation and as a regulator of p35 expression. Genes Dev 2006; 20: 836–47.
76. StacchiottiA, RezzaniR, RodellaL, et al. Cell-specific expression of heat shock transcription factors 1 and 2 in unstressed rat spinal cord. Neurosci Lett 1999; 268: 73–6.
77. WalshD, LiZ, WuY, NagataK. et al. Heat shock and the role of the HSPs during neural plate induction in early mammalian CNS and brain development. Cell Mol Life Sci 1997; 53: 198–211.
78. WangX, GrammatikakisN, SiganouA, et al. Regulation of molecular chaperone gene transcription involves the serine phosphorylation, 14–3–3 epsilon binding, and cytoplasmic sequestration of heat shock factor 1. Mol Cell Biol 2003; 23: 6013–26.
79. HommaS, JinX, WangG, et al. Demyelination, astrogliosis, and accumulation of ubiquitinated proteins, hallmarks of CNS disease in hsf1-deficient mice. J Neurosci 2007; 27: 7974–86.
80. HuY, MivechiNF. HSF-1 interacts with Ral-binding protein 1 in a stress-responsive, multiprotein complex with HSP90 in vivo. J Biol Chem 2003; 278: 17299–306.
81. BuL, JinY, ShiY, et al. Mutant DNA-binding domain of HSF4 is associated with autosomal dominant lamellar and Marner cataract. Nat Genet 2002; 31: 276–8.
82. AkerfeltM, TrouilletD, MezgerV, et al. Heat shock factors at a crossroad between stress and development. Ann N Y Acad Sci 2007; 1113: 15–27.
83. Robinson, MB, Gifondorwa, DJ, MilliganC. Mechanisms of the motoneuron stress response and its relevance in neurodegeneration. In McNeillAS, ed. Neurodegeneration: Theory, Disorders and Treatments. Hauppauge, NY: Nova Publishers, 2010.
84. HuangL, ChenCH. Proteasome regulators: activators and inhibitors. Curr Med Chem 2009; 16: 931–9.
85. LantonenL. Nucleolar aggresomes as counterparts of cytoplasmic aggresomes in proteotoxic stress. Bioessays 2011; 33: 386–95.
86. AikenCT, KaakeRM, WangX, et al. Oxidative stress-mediated regulation of proteasome complexes. Mol Cell proteomics 2011; 10: 1–11.
87. SaxenaS, CaroniP. Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron 2011; 71: 35–48.
88. AtkinJD, FargMA, TurnerBJ, et al. Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1. J Biol Chem 2006; 281: 30152–65.
89. KikuchiH, AlmerG, YamashitaS, et al. Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model. Proc Natl Acad Sci U S A 2006; 103: 6025–30.
90. NagataT, IlievaH, MurakamiT, et al. Increased ER stress during motor neuron degeneration in a transgenic mouse model of amyotrophic lateral sclerosis. Neurol Res 2007; 29: 767–71.
91. TobisawaS, HozumiY, ArawakaS, et al. Mutant SOD1 linked to familial amyotrophic lateral sclerosis, but not wild-type SOD1, induces ER stress in COS7 cells and transgenic mice. Biochem Biophys Res Commun 2003; 303: 496–503.
92. UrushitaniM, EzziSA, MatsuoA, et al. The endoplasmic reticulum-Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS. FASEB J 2008; 22: 2476–87.
93. SaxenaS, CabuyE, CaroniP. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat Neurosci 2009; 12: 627–36.
94. BanerjeeR, BealMF, ThomasB. Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications. Trends Neurosci 2010; 33: 541–9.
95. KroemerG, LevineB. Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol 2008; 9: 1004–10.
96. YangZ, KlionskyDJ. Eaten alive: a history of macroautophagy. Nat Cell Biol 2010; 12: 814–22.
97. HastyP. Rapamycin: the cure for all that ails. J Mol Cell Biol 2010; 2: 17–19.
98. MizushimaN, LevineB, CuervoAM, et al. Autophagy fights disease through cellular self-digestion. Nature 2008; 451: 1069–75.
99. WongE, CuervoAM. Autophagy gone awry in neurodegenerative diseases. Nat Neurosci 2010; 13: 805–11.
100. NairU, JotwaniA, GengJ, et al. SNARE proteins are required for macroautophagy. Cell 2011; 146: 290–302.
101. KomatsuM, IchimuraY. Physiological significance of selective degradation of p62 by autophagy. FEBS Lett 2010; 584: 1374–8.
102. RavikumarB, Acevedo-ArozenaA, ImarisioS, et al. Dynein mutations impair autophagic clearance of aggregate-prone proteins. Nat Genet 2005; 37: 771–6.
103. KlionskyDJ, OhsumiY. Vacuolar import of proteins and organelles from the cytoplasm. Annu Rev Cell Dev Biol 1999; 15: 1–32.
104. EskelinenEL, IllertAL, TanakaY, et al. Role of LAMP-2 in lysosome biogenesis and autophagy. Mol Biol Cell 2002; 13: 3355–68.
105. IwataA, RileyBE, JohnstonJA, et al. HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin. J Biol Chem 2005; 280: 40282–92.
106. HaraT, NakamuraK, MatsuiM, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006; 441: 885–9.
107. KomatsuM, WaguriS, ChibaT, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006; 441: 880–4.
108. TanakaY, GuhdeG, SuterA, et al. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature 2000; 406: 902–6.
109. Portera-CailliauC, HedreenJC, PriceDL, et al. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J Neurosci 1995; 15: 3775–87.
110. GafniJ, HermelE, YoungJE, et al. Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain/caspase fragments in the nucleus. J Biol Chem 2004; 279: 20211–20.
111. WellingtonCL, EllerbyLM, GutekunstCA, et al. Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington’s disease. J Neurosci 2002; 22: 7862–72.
112. Tellez-NagelI, JohnsonAB, TerryRD. Studies on brain biopsies of patients with Huntington’s chorea. J Neuropathol Exp Neurol 1974; 33: 308–32.
113. RavikumarB, VacherC, BergerZ, et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 2004; 36: 585–95.
114. RavikumarB, DudenR, RubinszteinDC. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum Mol Genet 2002; 11: 1107–17.
115. SarkarS, DaviesJE, HuangZ, et al. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J Biol Chem 2007; 282: 5641–52.
116. BauerPO, GoswamiA, WongHK, et al. Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein. Nat Biotechnol 2010; 28: 256–63.
117. PandeyUB, NieZ, BatleviY, et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 2007; 447: 859–63.
118. LevyOA, MalageladaC, GreeneLA. Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps. Apoptosis 2009; 14: 478–500.
119. AngladeP, VyasS, Javoy-AgidF, et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson’s disease. Histol Histopathol 1997; 12: 25–31.
120. ZhuJH, GuoF, ShelburneJ, et al. Localization of phosphorylated ERK/MAP kinases to mitochondria and autophagosomes in Lewy body diseases. Brain Pathol 2003; 13: 473.
121. CuervoAM, StefanisL, FredenburgR, et al. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 2004; 305: 1292–5.
122. YangQ, SheH, GearingM, et al. Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy. Science 2009; 323: 124–7.
123. MatsudaN, SatoS, ShibaK, et al. PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J Cell Biol 2010; 189: 211–21.
124. LeeJY, NaganoY, TaylorJP, et al. Disease-causing mutations in parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy. J Cell Biol 2010; 189: 671–9.
125. DehayB, BoveJ, Rodriguez-MuelaN, et al. Pathogenic lysosomal depletion in Parkinson’s disease. J Neurosci 2010; 30: 12535–44.
126. GouldTW, BussRR, VinsantS, et al. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J Neurosci 2006; 26: 8774–86.
127. LairdFM, FarahMH, AckerleyS, et al. Motor neuron disease occurring in a mutant dynactin mouse model is characterized by defects in vesicular trafficking. J Neurosci 2008; 28: 1997–2005.
128. MorimotoN, NagaiM, OhtaY, et al. Increased autophagy in transgenic mice with a G93A mutant SOD1 gene. Brain Res 2007; 1167: 112–17.
129. CrippaV, SauD, RusminiP, et al. The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS). Hum Mol Genet 2010; 19: 3440–56.
130. HetzC, ThielenP, MatusS, et al. XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev 2009; 23: 2294–306.
131. LeeJA, LiuL, GaoFB. Autophagy defects contribute to neurodegeneration induced by dysfunctional ESCRT-III. Autophagy 2009; 5: 1070–2.
132. ParkinsonN, IncePG, SmithMO, et al. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology 2006; 67: 1074–7.
133. FilimonenkoM, StuffersS, RaiborgC, et al. Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. J Cell Biol 2007; 179: 485–500.
134. PriceJL, KoAI, WadeMJ, et al. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch Neurol 2001; 58: 1395–402.
135. WestMJ, ColemanPD, FloodDG, et al. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer’s disease. Lancet 1994; 344: 769–72.
136. Gómez-IslaT, PriceJL, McKeelDW Jr, et al. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer’s disease. J Neurosci 1996; 16: 4491–500.
137. ColursoGJ, NilsonJE, VervoortLG. Quantitative assessment of DNA fragmentation and beta-amyloid deposition in insular cortex and midfrontal gyrus from patients with Alzheimer’s disease. Life Sci 2003; 73: 1795–803.
138. NixonRA. Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci 2007; 120: 4081–91.
139. CataldoAM, PeterhoffCM, SchmidtSD, et al. Presenilin mutations in familial Alzheimer disease and transgenic mouse models accelerate neuronal lysosomal pathology. J Neuropathol Exp Neurol 2004; 63: 821–30.
140. PickfordF, MasliahE, BritschgiM, et al. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest 2008; 118: 2190–9.
141. SpilmanP, PodlutskayaN, HartMJ, et al. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer’s disease. PLoS One 2010; 5: e9979.
142. BergerZ, RavikumarB, MenziesFM, et al. Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum Mol Genet 2006; 15: 433–42.
143. WangT, LaoU, EdgarBA. TOR-mediated autophagy regulates cell death in Drosophila neurodegenerative disease. J Cell Biol 2009; 186: 703–11.
144. CopaniA, UbertiD, SortinoMA, et al. Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path?Trends Neurosci 2001; 24: 25–31.
145. BoyceM, YuanJ. Cellular response to endoplasmic reticulum stress: a matter of life or death. Cell Death Differ 2006; 13: 363–73.
146. LindholmD, WootzH, KorhonenL. ER stress and neurodegenerative diseases. Cell Death Differ 2006; 13: 385–92.
147. PrahladV, MorimotoRI. Integrating the stress response: lessons for neurodegenerative diseases from C. elegans. Trends Cell Biol 2009; 19: 52–61.